Global Intravenous Immunoglobulin (IVIg) Market Research Report 2021

Global Intravenous Immunoglobulin (IVIg) Market Research Report 2021

Table of Contents
1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
1.2 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3.1 Intravenous Immunoglobulin (IVIg) Sales Comparison by Application: (2021-2027)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2016-2027
1.4.2 Global Intravenous Immunoglobulin (IVIg) Sales 2016-2027
1.4.3 Intravenous Immunoglobulin (IVIg) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Intravenous Immunoglobulin (IVIg) Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites, Area Served, Product Type
2.5 Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
2.5.1 Intravenous Immunoglobulin (IVIg) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue
2.5.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario by Region
3.1 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.3.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country
3.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country
3.4.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region
3.5.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region
3.5.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.6.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country
3.6.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country
3.7.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Intravenous Immunoglobulin (IVIg) Historic Market Analysis by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)
4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2016-2021)
5 Global Intravenous Immunoglobulin (IVIg) Historic Market Analysis by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2021)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Baxter Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Grifols Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CSL Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Octapharma Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biotest Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Kedrion Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hualan Bio Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CNBG Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Shanghai RAAS Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 CBPO Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 LFB Group Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 BPL Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sichuan Yuanda Shuyang Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
7.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
7.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intravenous Immunoglobulin (IVIg) Distributors List
8.3 Intravenous Immunoglobulin (IVIg) Customers
9 Intravenous Immunoglobulin (IVIg) Market Dynamics
9.1 Intravenous Immunoglobulin (IVIg) Industry Trends
9.2 Intravenous Immunoglobulin (IVIg) Growth Drivers
9.3 Intravenous Immunoglobulin (IVIg) Market Challenges
9.4 Intravenous Immunoglobulin (IVIg) Market Restraints
10 Global Market Forecast
10.1 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Type (2022-2027)
10.2 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Application (2022-2027)
10.3 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Comparison by Application (2021-2027)
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Intravenous Immunoglobulin (IVIg) Covered in This Study
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Manufacturers (2016-2021)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers (2016-2021)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites and Area Served
Table 11. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 12. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 16. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 19. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 20. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 22. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 23. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 24. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 27. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 31. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 32. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 35. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 38. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2016-2021)
Table 39. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 40. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2016-2021)
Table 42. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2016-2021)
Table 43. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2016-2021)
Table 44. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 45. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2016-2021)
Table 47. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2016-2021)
Table 48. Baxter Corporation Information
Table 49. Baxter Description and Business Overview
Table 50. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 51. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 52. Baxter Recent Developments/Updates
Table 53. Grifols Corporation Information
Table 54. Grifols Description and Business Overview
Table 55. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 56. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 57. Grifols Recent Developments/Updates
Table 58. CSL Corporation Information
Table 59. CSL Description and Business Overview
Table 60. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 61. CSL Intravenous Immunoglobulin (IVIg) Product
Table 62. CSL Recent Developments/Updates
Table 63. Octapharma Corporation Information
Table 64. Octapharma Description and Business Overview
Table 65. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 66. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 67. Octapharma Recent Developments/Updates
Table 68. Biotest Corporation Information
Table 69. Biotest Description and Business Overview
Table 70. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 71. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 72. Biotest Recent Developments/Updates
Table 73. Kedrion Corporation Information
Table 74. Kedrion Description and Business Overview
Table 75. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 76. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 77. Kedrion Recent Developments/Updates
Table 78. Hualan Bio Corporation Information
Table 79. Hualan Bio Description and Business Overview
Table 80. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 81. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 82. Hualan Bio Recent Developments/Updates
Table 83. CNBG Corporation Information
Table 84. CNBG Description and Business Overview
Table 85. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 86. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 87. CNBG Recent Developments/Updates
Table 88. Shanghai RAAS Corporation Information
Table 89. Shanghai RAAS Description and Business Overview
Table 90. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 91. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 92. Shanghai RAAS Recent Developments/Updates
Table 93. CBPO Corporation Information
Table 94. CBPO Description and Business Overview
Table 95. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 96. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 97. CBPO Recent Developments/Updates
Table 98. LFB Group Corporation Information
Table 99. LFB Group Description and Business Overview
Table 100. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 101. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 102. LFB Group Recent Developments/Updates
Table 103. BPL Corporation Information
Table 104. BPL Description and Business Overview
Table 105. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 106. BPL Intravenous Immunoglobulin (IVIg) Product
Table 107. BPL Recent Developments/Updates
Table 108. Sichuan Yuanda Shuyang Corporation Information
Table 109. Sichuan Yuanda Shuyang Description and Business Overview
Table 110. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 111. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 112. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Intravenous Immunoglobulin (IVIg) Distributors List
Table 116. Intravenous Immunoglobulin (IVIg) Customers List
Table 117. Intravenous Immunoglobulin (IVIg) Market Trends
Table 118. Intravenous Immunoglobulin (IVIg) Growth Drivers
Table 119. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 120. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2022-2027) & (K Bottle)
Table 121. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2022-2027) & (K Bottle)
Table 125. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2022-2027) & (K Bottle)
Table 129. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Share by Type in 2020 & 2027
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Market Share by Application in 2020 & 2027
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Intravenous Immunoglobulin (IVIg) Market Size 2016-2027 (US$ Million)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales 2016-2027 (K Bottle)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2020
Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players: Market Share by Revenue in 2020
Figure 16. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Figure 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2020
Figure 19. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Figure 20. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in 2020
Figure 21. U.S. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2016-2021)
Figure 46. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application (2016-2021)
Figure 47. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application in 2020
Figure 48. Revenue Share of Intravenous Immunoglobulin (IVIg) by Application (2016-2021)
Figure 49. Revenue Share of Intravenous Immunoglobulin (IVIg) by Application in 2020
Figure 50. Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure 51. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 52. Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs